Literature DB >> 21890211

Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder.

Julia Sacher1, Jane Neumann, Tillmann Fünfstück, Alexandra Soliman, Arno Villringer, Matthias L Schroeter.   

Abstract

BACKGROUND: Depression has a lifetime prevalence of up to 20%. Neuroimaging methods have revealed various structural and functional changes that occur in a human brain during a depressive episode. However, we still lack information concerning the extent to which structural and functional changes co-occur in a depressed brain. Furthermore, it is difficult to evaluate from a merely qualitative literature review what regional brain changes in volume and activation are robust across depressed patient samples and consistent across imaging centers. METHODOLOGY AND PRINCIPLE
FINDINGS: This study is a meta-analysis from 10 selected studies published previously. We applied the statistical anatomical/activation likelihood estimate method (ALE) in a total of 176 depressed patients and 175 controls for the MRI modality and in a total of 102 depressed patients and 94 controls for the PET modality to quantitatively identify those brain regions that show concordant alteration in the midst of a depressive episode across imaging modalities and study sites. We find a convergent change in the limbic-cortical brain circuit in depression compared to controls of both Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) data. The specific changes include lower gray matter volumes in the amygdala, the dorsal frontomedian cortex, and the right paracingulate cortex, as well as increases in glucose metabolism in the right subgenual and pregenual anterior cingulate cortices.
CONCLUSIONS/SIGNIFICANCE: Our current findings represent an important first step towards a more focused approach to neuroimaging unipolar depression. The regions identified could serve as a specific region-of-interest-for-disease template for both individual in vivo imaging studies and postmortem histopathologic exploration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21890211     DOI: 10.1016/j.jad.2011.08.001

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  111 in total

1.  Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample.

Authors:  Hans Jörgen Grabe; Katharina Wittfeld; Sandra Van der Auwera; Deborah Janowitz; Katrin Hegenscheid; Mohamad Habes; Georg Homuth; Sven Barnow; Ulrich John; Matthias Nauck; Henry Völzke; Henriette Meyer zu Schwabedissen; Harald Jürgen Freyberger; Norbert Hosten
Journal:  Hum Brain Mapp       Date:  2016-01-27       Impact factor: 5.038

2.  Cerebral perfusion disturbances in chronic mild traumatic brain injury correlate with psychoemotional outcomes.

Authors:  Efrosini Papadaki; Eleftherios Kavroulakis; Katina Manolitsi; Dimitrios Makrakis; Emmanouil Papastefanakis; Pelagia Tsagaraki; Styliani Papadopoulou; Alexandros Zampetakis; Margarita Malliou; Antonios Vakis; Panagiotis Simos
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

3.  Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice.

Authors:  Shui-bing Liu; Rong Zhao; Xu-sheng Li; Hong-ju Guo; Zhen Tian; Nan Zhang; Guo-dong Gao; Ming-gao Zhao
Journal:  Neuromolecular Med       Date:  2014-03-01       Impact factor: 3.843

4.  Acute Hyperglycemia Increases Brain Pregenual Anterior Cingulate Cortex Glutamate Concentrations in Type 1 Diabetes.

Authors:  Nicolas R Bolo; Alan M Jacobson; Gail Musen; Matcheri S Keshavan; Donald C Simonson
Journal:  Diabetes       Date:  2020-04-15       Impact factor: 9.461

5.  The human amygdala and pain: evidence from neuroimaging.

Authors:  Laura E Simons; Eric A Moulton; Clas Linnman; Elizabeth Carpino; Lino Becerra; David Borsook
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

6.  Developmental Trajectories of the Orbitofrontal Cortex and Anhedonia in Middle Childhood and Risk for Substance Use in Adolescence in a Longitudinal Sample of Depressed and Healthy Preschoolers.

Authors:  Joan L Luby; Arpana Agrawal; Andy Belden; Diana Whalen; Rebecca Tillman; Deanna M Barch
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

7.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

Review 8.  Practical recommendations to conduct a neuroimaging meta-analysis for neuropsychiatric disorders.

Authors:  Masoud Tahmasian; Amir A Sepehry; Fateme Samea; Tina Khodadadifar; Zahra Soltaninejad; Nooshin Javaheripour; Habibolah Khazaie; Mojtaba Zarei; Simon B Eickhoff; Claudia R Eickhoff
Journal:  Hum Brain Mapp       Date:  2019-08-04       Impact factor: 5.038

9.  Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.

Authors:  Shehzad Basaria; Ravi Jasuja; Grace Huang; Whitney Wharton; Hong Pan; Karol Pencina; Zhuoying Li; Thomas G Travison; Jag Bhawan; Renaud Gonthier; Fernand Labrie; Alain Y Dury; Carlo Serra; Allen Papazian; Michael O'Leary; Sami Amr; Thomas W Storer; Emily Stern; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2016-09-23       Impact factor: 5.958

10.  Impaired Frontal-Limbic White Matter Maturation in Children at Risk for Major Depression.

Authors:  Yuwen Hung; Zeynep M Saygin; Joseph Biederman; Dina Hirshfeld-Becker; Mai Uchida; Oliver Doehrmann; Michelle Han; Xiaoqian J Chai; Tara Kenworthy; Pavel Yarmak; Schuyler L Gaillard; Susan Whitfield-Gabrieli; John D E Gabrieli
Journal:  Cereb Cortex       Date:  2017-09-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.